Predicting of hepatic steatosis in living liver donor via CT liver attenuation index (LAI) and fibroscan controlled attenuation parameter (CAP) correlation with biopsy result
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Predicting of hepatic steatosis in living liver donor via CT liver attenuation index (LAI) and fibroscan controlled attenuation parameter (CAP) correlation with biopsy result ; volume:55 ; number:1 ; day:2 ; month:9 ; year:2024 ; pages:1-9 ; date:12.2024
The Egyptian Journal of Radiology and Nuclear Medicine ; 55, Heft 1 (2.9.2024), 1-9, 12.2024
- Urheber
-
Mahfouz, Somaia Mohammed Ali
Mohamed, Fatma Salah eldin
Chalabi, Nivine Abdel Moneium
Abdel-Rahman, Hazem Ibrahim
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43055-024-01335-7
- URN
-
urn:nbn:de:101:1-2411172225497.633302243568
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mahfouz, Somaia Mohammed Ali
- Mohamed, Fatma Salah eldin
- Chalabi, Nivine Abdel Moneium
- Abdel-Rahman, Hazem Ibrahim
- SpringerLink (Online service)
Ähnliche Objekte (12)
Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients
Simultaneous imaging of ultrasonic relative backscatter and attenuation coefficients for quantitative liver steatosis assessment
Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice
CT attenuation values predict liver injury in COVID-19 patients
Correction to: Deep attenuation transducer to measure liver stiffness in obese patients with liver disease
Effect of Meal Ingestion on Liver Stiffness and Controlled Attenuation Parameter
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
Diagnostic performance of two-dimensional shear wave elastography and attenuation imaging for fibrosis and steatosis assessment in chronic liver disease
Human liver organoid: modeling liver steatosis and beyond
Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients
Simultaneous imaging of ultrasonic relative backscatter and attenuation coefficients for quantitative liver steatosis assessment
Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice
CT attenuation values predict liver injury in COVID-19 patients
Correction to: Deep attenuation transducer to measure liver stiffness in obese patients with liver disease
Effect of Meal Ingestion on Liver Stiffness and Controlled Attenuation Parameter
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
Diagnostic performance of two-dimensional shear wave elastography and attenuation imaging for fibrosis and steatosis assessment in chronic liver disease
Human liver organoid: modeling liver steatosis and beyond
Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients
Simultaneous imaging of ultrasonic relative backscatter and attenuation coefficients for quantitative liver steatosis assessment
Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice
CT attenuation values predict liver injury in COVID-19 patients
Correction to: Deep attenuation transducer to measure liver stiffness in obese patients with liver disease
Effect of Meal Ingestion on Liver Stiffness and Controlled Attenuation Parameter
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
Diagnostic performance of two-dimensional shear wave elastography and attenuation imaging for fibrosis and steatosis assessment in chronic liver disease